UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Long-term forecasting of a motor outcome following rehabilitation in chronic stroke via a hierarchical bayesian dynamic model

Journal of neuroengineering and rehabilitation, 2023-06, Vol.20 (1), p.83-83, Article 83

2023

Volltextzugriff (PDF)

Editorial: Model-informed decision making in the preclinical stages of pharmaceutical research and development

Frontiers in pharmacology, 2023-04, Vol.14, p.1184914-1184914

2023

Volltextzugriff (PDF)

Pharmacokinetics of Doxycycline in Adults with Cystic Fibrosis

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.70-74

2012

Volltextzugriff (PDF)

Analysis of Complex Absorption After Multiple Dosing: Application to the Interaction Between the P-glycoprotein Substrate Talinolol and Rifampicin

Pharmaceutical research, 2022-12, Vol.39 (12), p.3293-3300

2022

Volltextzugriff (PDF)

An in-silico modeling approach to separate exogenous and endogenous plasma insulin appearance, with application to inhaled insulin

Scientific reports, 2024-05, Vol.14 (1), p.10936-13, Article 10936

2024

Volltextzugriff (PDF)

Monoclonal Antibody Pharmacokinetics in Cynomolgus Monkeys Following Subcutaneous Administration: Physiologically Based Model Predictions from Physiochemical Properties

The AAPS journal, 2022-12, Vol.25 (1), p.5, Article 5

2022

Volltextzugriff (PDF)

Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling

Journal of pharmacokinetics and pharmacodynamics, 2020-10, Vol.47 (5), p.385-409

2020

Volltextzugriff (PDF)

The Efficiency, Efficacy, and Retention of Task Practice in Chronic Stroke

Neurorehabilitation and neural repair, 2020-10, Vol.34 (10), p.881-890

2020

Volltextzugriff (PDF)

Physiologically Based Modeling to Predict Monoclonal Antibody Pharmacokinetics in Humans from in vitro Physiochemical Properties

mAbs, 2022, Vol.14 (1), p.2056944

2022

Volltextzugriff (PDF)

Plasma Pharmacokinetics, Oral Bioavailability, and Interspecies Scaling of the DNA Methyltransferase Inhibitor, Zebularine

Clinical cancer research, 2005-05, Vol.11 (10), p.3862-3868

2005

Volltextzugriff (PDF)

Glucagon increases insulin levels by stimulating insulin secretion without effect on insulin clearance in mice

Peptides (New York, N.Y. : 1980), 2017-02, Vol.88, p.74-79

2017

Volltextzugriff (PDF)

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis

Antimicrobial agents and chemotherapy, 2017-10, Vol.61 (10)

2017

Volltextzugriff (PDF)

Nonlinear random effects mixture models: Maximum likelihood estimation via the EM algorithm

Computational statistics & data analysis, 2007-08, Vol.51 (12), p.6614-6623

2007

Volltextzugriff (PDF)

Biokinetic modeling of nanoparticle interactions with lung alveolar epithelial cells: uptake, intracellular processing, and egress

American journal of physiology. Regulatory, integrative and comparative physiology, 2021-01, Vol.320 (1), p.R36-R43

2021

Volltextzugriff (PDF)

Population-based meta-analysis of roxithromycin pharmacokinetics: dosing implications of saturable absorption and protein binding

Journal of antimicrobial chemotherapy, 2017-04, Vol.72 (4), p.1129-1136

2017

Volltextzugriff (PDF)

Non-linear IV pharmacokinetics of the ATR inhibitor berzosertib (M6620) in mice

Cancer chemotherapy and pharmacology, 2024-05

2024

Volltextzugriff (PDF)

Open‐source maximum a posteriori‐bayesian dosing AdDS to current therapeutic drug monitoring: Adapting to the era of individualized therapy

Pharmacotherapy, 2021-11, Vol.41 (11), p.953-963

2021

Volltextzugriff (PDF)

Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a

The Journal of infectious diseases, 2016-10, Vol.214 (8), p.1192-1197

2016

Volltextzugriff (PDF)

Predicting Chemotherapy-Induced Neutropenia and Granulocyte Colony–Stimulating Factor Response Using Model-Based In Vitro to Clinical Translation

The AAPS journal, 2020-11, Vol.22 (6), p.143-143, Article 143

2020

Volltextzugriff (PDF)

An Analysis of Glucose Effectiveness in Subjects With or Without Type 2 Diabetes via Hierarchical Modeling

Frontiers in endocrinology (Lausanne), 2021-03, Vol.12, p.641713-641713

2021

Volltextzugriff (PDF)

Population pharmacokinetic/pharmacodynamic mixture models via maximum a posteriori estimation

Computational statistics & data analysis, 2009-10, Vol.53 (12), p.3907-3915

2009

Volltextzugriff (PDF)

Pharmacokinetics of Tedizolid in Plasma and Sputum of Adults with Cystic Fibrosis

Antimicrobial agents and chemotherapy, 2018-09, Vol.62 (9)

2018

Volltextzugriff (PDF)

A physiological model of granulopoiesis to predict clinical drug induced neutropenia from in vitro bone marrow studies: with application to a cell cycle inhibitor

Journal of pharmacokinetics and pharmacodynamics, 2020-04, Vol.47 (2), p.163-182

2020

Volltextzugriff (PDF)

Vitreous VEGF Clearance Is Increased after Vitrectomy

Investigative ophthalmology & visual science, 2010-04, Vol.51 (4), p.2135

2010

Volltextzugriff (PDF)

Characteristics of Passive Solute Transport across Primary Rat Alveolar Epithelial Cell Monolayers

Membranes (Basel), 2021-04, Vol.11 (5), p.331

2021

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Englisch
(102)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term forecasting of a motor outcome following rehabilitation in chronic stroke via a hierarchical bayesian dynamic model

Editorial: Model-informed decision making in the preclinical stages of pharmaceutical research and development

Pharmacokinetics of Doxycycline in Adults with Cystic Fibrosis

Analysis of Complex Absorption After Multiple Dosing: Application to the Interaction Between the P-glycoprotein Substrate Talinolol and Rifampicin

An in-silico modeling approach to separate exogenous and endogenous plasma insulin appearance, with application to inhaled insulin

Monoclonal Antibody Pharmacokinetics in Cynomolgus Monkeys Following Subcutaneous Administration: Physiologically Based Model Predictions from Physiochemical Properties

Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling

The Efficiency, Efficacy, and Retention of Task Practice in Chronic Stroke

Physiologically Based Modeling to Predict Monoclonal Antibody Pharmacokinetics in Humans from in vitro Physiochemical Properties

Plasma Pharmacokinetics, Oral Bioavailability, and Interspecies Scaling of the DNA Methyltransferase Inhibitor, Zebularine

Glucagon increases insulin levels by stimulating insulin secretion without effect on insulin clearance in mice

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis

Nonlinear random effects mixture models: Maximum likelihood estimation via the EM algorithm

Biokinetic modeling of nanoparticle interactions with lung alveolar epithelial cells: uptake, intracellular processing, and egress

Population-based meta-analysis of roxithromycin pharmacokinetics: dosing implications of saturable absorption and protein binding

Non-linear IV pharmacokinetics of the ATR inhibitor berzosertib (M6620) in mice

Open‐source maximum a posteriori‐bayesian dosing AdDS to current therapeutic drug monitoring: Adapting to the era of individualized therapy

Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a

Predicting Chemotherapy-Induced Neutropenia and Granulocyte Colony–Stimulating Factor Response Using Model-Based In Vitro to Clinical Translation

An Analysis of Glucose Effectiveness in Subjects With or Without Type 2 Diabetes via Hierarchical Modeling

Population pharmacokinetic/pharmacodynamic mixture models via maximum a posteriori estimation

Pharmacokinetics of Tedizolid in Plasma and Sputum of Adults with Cystic Fibrosis

A physiological model of granulopoiesis to predict clinical drug induced neutropenia from in vitro bone marrow studies: with application to a cell cycle inhibitor

Vitreous VEGF Clearance Is Increased after Vitrectomy

Characteristics of Passive Solute Transport across Primary Rat Alveolar Epithelial Cell Monolayers

Suchergebnisse filtern